$40.00
Melanotan 2 (MT-II) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (alpha-MSH). It is a non-selective agonist at the melanocortin receptors and is used in laboratory work as a reference agonist in melanocortin receptor pharmacology. Melanotan 2 is not an authorized drug in Canada.
Melanotan 2 is a synthetic lactam-cyclic heptapeptide analogue of the peptide hormone alpha-melanocyte-stimulating hormone (alpha-MSH). It was developed at the University of Arizona during structure-activity work on alpha-MSH analogues. It is the parent structure from which bremelanotide (PT-141) was later derived.
Regulatory status in Canada
Melanotan 2 is not an authorized drug in Canada and carries no Drug Identification Number. Health Canada’s April 2026 advisory on unauthorized injectable peptide drugs sold online names melanotan I and melanotan II among the products it has seized, and warns that unauthorized products of this kind may contain contaminants including solvents, heavy metals, particulates and microbial material. The material supplied here is a research chemical for laboratory use and is not a drug product.
Technical Specifications
Research Context
Melanotan 2 is described in the pharmacology literature as a non-selective agonist across the melanocortin receptor family. Laboratory uses include:
These are laboratory applications. Nothing here describes an effect in a person or an animal outside a controlled study.
Storage and Handling
Testing and Quality Control
Every batch of Melanotan 2 is released against the following checks:
1. HPLC (high-performance liquid chromatography): to confirm a purity profile of ≥99.0%.
2. MS (mass spectrometry): to confirm the molecular weight and identity of the cyclic peptide.
3. Visual inspection: to confirm the consistency and integrity of the lyophilized cake.
For laboratory research use only. Not for human or veterinary use.
Further reading